Cargando…
Expression of Mesenchymal and α-Cell Phenotypic Markers in Islet β-Cells in Recently Diagnosed Diabetes
OBJECTIVE: Relative contributions of reversible β-cell dysfunction and true decrease in β-cell mass in type 2 diabetes remain unclear. Definitive rodent lineage-tracing studies have identified β-cell dedifferentiation and subsequent reprogramming to α-cell fate as a novel mechanism underlying β-cell...
Autores principales: | White, Michael G., Marshall, Helen L., Rigby, Rebecca, Huang, Guo Cai, Amer, Aimen, Booth, Trevor, White, Steve, Shaw, James A.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816907/ https://www.ncbi.nlm.nih.gov/pubmed/24062329 http://dx.doi.org/10.2337/dc13-0705 |
Ejemplares similares
-
Differentiation of Mesenchymal Stem Cells Derived from Pancreatic Islets and Bone Marrow into Islet-Like Cell Phenotype
por: Zanini, Cristina, et al.
Publicado: (2011) -
Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda
por: Kibirige, Davis, et al.
Publicado: (2022) -
Recent progress in pancreatic islet cell therapy
por: Sim, Erinn Zixuan, et al.
Publicado: (2021) -
Using Mesenchymal Stromal Cells in Islet Transplantation
por: Arzouni, Ahmed A., et al.
Publicado: (2018) -
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
por: Barachini, Serena, et al.
Publicado: (2023)